Solid Biosciences Inc. (SLDB) › Operating IncomeSolid Biosciences Inc. (SLDB) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$25.58M2017: -$54.86M2018: -$75.69M2019: -$119.32M2020: -$88.41M2021: -$72.25M2022: -$106.45M2023: -$104.25M2024: -$129.73M2025: -$179.21M-$179.21M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$179.21M-38.1%2024-$129.73M-24.4%2023-$104.25M+2.1%2022-$106.45M-47.3%2021-$72.25M+18.3%2020-$88.41M+25.9%2019-$119.32M-57.6%2018-$75.69M-38.0%2017-$54.86M-114.5%2016-$25.58M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share